483 GlaxoSmithKline Apr 2000

483 GlaxoSmithKline Apr 2000

Kathleen Culver FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline - Zebulon, NC, United States facility and issued inspectional observations (via FDA 483) on 24 Apr 2000.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Apr 2000
  • Location: Zebulon, United States
  • FEI: 1033964
Add To Cart